Analysts Set CVS Health Co. (NYSE:CVS) Target Price at $67.65

Shares of CVS Health Co. (NYSE:CVS) have been given a consensus recommendation of “Moderate Buy” by the twenty-one brokerages that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $70.29.

A number of research firms have recently weighed in on CVS. Leerink Partnrs raised CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Wednesday. Mizuho reduced their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. UBS Group cut their price target on CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 11th. TD Cowen boosted their target price on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Finally, Wells Fargo & Company increased their price target on shares of CVS Health from $68.00 to $73.00 and gave the stock an “overweight” rating in a research report on Thursday.

CVS Health Stock Down 1.0 %

Shares of NYSE CVS opened at $65.71 on Thursday. The business has a 50-day simple moving average of $51.11 and a two-hundred day simple moving average of $56.08. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The company has a market cap of $82.68 billion, a P/E ratio of 16.68, a P/E/G ratio of 0.60 and a beta of 0.61. CVS Health has a 52 week low of $43.56 and a 52 week high of $80.75.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. Research analysts anticipate that CVS Health will post 5.14 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.05%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio is presently 67.51%.

Hedge Funds Weigh In On CVS Health

A number of institutional investors and hedge funds have recently made changes to their positions in CVS. MidAtlantic Capital Management Inc. bought a new position in shares of CVS Health in the 3rd quarter valued at about $25,000. Livelsberger Financial Advisory bought a new stake in shares of CVS Health in the 3rd quarter valued at approximately $31,000. Legacy Investment Solutions LLC purchased a new position in shares of CVS Health in the 3rd quarter worth approximately $31,000. Reston Wealth Management LLC bought a new position in shares of CVS Health during the 3rd quarter valued at approximately $32,000. Finally, Ridgewood Investments LLC raised its holdings in CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 450 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.